Aphea.Bio is a leading R&D company developing novel and superior agricultural biologicals based on naturally occurring microoganisms. We concentrate on products that help reducing synthetic fertilizers (biostimulants) and chemical pesticides (biocontrol agents) sustainably in maize and wheat.
Aphea.Bio’s ambition is to be the global impact innovator in microbial product development addressing all important indications: biostimulants, biofungicides, bioinsecticides and bioherbicides. Through its unique, high-throughput technology platform Aphea.Bio has built a richly-filled, well advanced candidate product portfolio. The first biostimulant product launch is anticipated for 2023.
The company can count on a solid scientific team and strong leadership team with many years of experience in science and business and is led by Dr. Isabel Vercauteren as CEO (ex-Bayer, ex-DevGen).
